IL-22 promotes the progression of breast cancer through regulating HOXB-AS5
Authors:
Open Access
- 19 October 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (61) , 103601-103612
Abstract
IL-22 promotes the progression of breast cancer through regulating HOXB-AS5 IL-22 promotes the progression of breast cancer through regulating HOXB-AS5Keywords
This publication has 32 references indexed in Scilit:
- IL-22 is related to development of human colon cancer by activation of STAT3BMC Cancer, 2013
- Conserved boundary elements from the Hox complex of mosquito, Anopheles gambiaeNucleic Acids Research, 2012
- Heterogeneity in breast cancerJournal of Clinical Investigation, 2011
- mTOR Kinase Inhibitor AZD8055 Enhances the Immunotherapeutic Activity of an Agonist CD40 Antibody in Cancer TreatmentCancer Research, 2011
- Long noncoding RNAs and human diseaseTrends in Cell Biology, 2011
- Small molecule inhibition of arylamine N-acetyltransferase Type I inhibits proliferation and invasiveness of MDA-MB-231 breast cancer cellsBiochemical and Biophysical Research Communications, 2010
- Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodelingJournal of Clinical Investigation, 2009
- NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K MutationsCancer Research, 2008
- Cancer-related inflammationNature, 2008
- Modulating Hox gene functions during animal body patterningNature Reviews Genetics, 2005